First human tests begin for new antibody drug
NCT ID NCT07090655
Summary
This early study aims to check the safety and side effects of a new antibody drug called budoprutug in healthy people. About 38 volunteers will receive either the drug or a placebo as a single injection under the skin or into a vein. Researchers will monitor how the body handles the drug and look for any reactions.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Nucleus Network Brisbane
Brisbane, Australia
Conditions
Explore the condition pages connected to this study.